List of Tables

Table 1. Targeted Antitumor Drugs Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Targeted Antitumor Drugs Market Restraints

Table 3. Targeted Antitumor Drugs Market Trends

Table 4. Targeted Antitumor Drugs Industry Policy

Table 5. Global Targeted Antitumor Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Targeted Antitumor Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Targeted Antitumor Drugs Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 8. Global Targeted Antitumor Drugs Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Targeted Antitumor Drugs Average Selling Price (ASP) by Company, (2020-2025) & (US$/Unit)

Table 10. Global Targeted Antitumor Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Targeted Antitumor Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Targeted Antitumor Drugs Manufacturers Product Type

Table 13. Head Office and Targeted Antitumor Drugs Production Site of Key Manufacturer

Table 14. Targeted Antitumor Drugs Capacity of Major Manufacturers and Future Plan

Table 15. China Targeted Antitumor Drugs Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Targeted Antitumor Drugs Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Targeted Antitumor Drugs Sales Quantity by Company, (2020-2025) & (K Units), Ranked Based on Sales in 2024

Table 18. China Targeted Antitumor Drugs Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Targeted Antitumor Drugs Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Units)

Table 20. Global Targeted Antitumor Drugs Production by Region, 2020-2025, (K Units)

Table 21. Global Targeted Antitumor Drugs Production Forecast by Region, 2026-2031, (K Units)

Table 22. Global Key Players of Targeted Antitumor Drugs Upstream (Raw Materials)

Table 23. Global Targeted Antitumor Drugs Typical Customers

Table 24. Targeted Antitumor Drugs Typical Distributors

Table 25. by Type, Global Targeted Antitumor Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Targeted Antitumor Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Targeted Antitumor Drugs Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Targeted Antitumor Drugs Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Table 30. By Country, Global Targeted Antitumor Drugs Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Targeted Antitumor Drugs Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Targeted Antitumor Drugs Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Table 34. By Country, Global Targeted Antitumor Drugs Sales Quantity Market Share, 2020-2031

Table 35. Roche Company Information, Head Office, Market Area, and Industry Position

Table 36. Roche Targeted Antitumor Drugs Models, Specifications, and Application

Table 37. Roche Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 38. Roche Company Profile and Main Business

Table 39. Roche Recent Developments

Table 40. Celgene Company Information, Head Office, Market Area, and Industry Position

Table 41. Celgene Targeted Antitumor Drugs Models, Specifications, and Application

Table 42. Celgene Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 43. Celgene Company Profile and Main Business

Table 44. Celgene Recent Developments

Table 45. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 46. Novartis Targeted Antitumor Drugs Models, Specifications, and Application

Table 47. Novartis Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 48. Novartis Company Profile and Main Business

Table 49. Novartis Recent Developments

Table 50. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position

Table 51. Johnson & Johnson Targeted Antitumor Drugs Models, Specifications, and Application

Table 52. Johnson & Johnson Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 53. Johnson & Johnson Company Profile and Main Business

Table 54. Johnson & Johnson Recent Developments

Table 55. Lilly Company Information, Head Office, Market Area, and Industry Position

Table 56. Lilly Targeted Antitumor Drugs Models, Specifications, and Application

Table 57. Lilly Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 58. Lilly Company Profile and Main Business

Table 59. Lilly Recent Developments

Table 60. AstraZeneca plc. Company Information, Head Office, Market Area, and Industry Position

Table 61. AstraZeneca plc. Targeted Antitumor Drugs Models, Specifications, and Application

Table 62. AstraZeneca plc. Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 63. AstraZeneca plc. Company Profile and Main Business

Table 64. AstraZeneca plc. Recent Developments

Table 65. Betta Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 66. Betta Pharmaceuticals Targeted Antitumor Drugs Models, Specifications, and Application

Table 67. Betta Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 68. Betta Pharmaceuticals Company Profile and Main Business

Table 69. Betta Pharmaceuticals Recent Developments

Table 70. Shanghai Henlius Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 71. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Models, Specifications, and Application

Table 72. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 73. Shanghai Henlius Biopharmaceutical Company Profile and Main Business

Table 74. Shanghai Henlius Biopharmaceutical Recent Developments

Table 75. Innovent Biologics Company Information, Head Office, Market Area, and Industry Position

Table 76. Innovent Biologics Targeted Antitumor Drugs Models, Specifications, and Application

Table 77. Innovent Biologics Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 78. Innovent Biologics Company Profile and Main Business

Table 79. Innovent Biologics Recent Developments

Table 80. Nanjing Shunxin Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 81. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Models, Specifications, and Application

Table 82. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 83. Nanjing Shunxin Pharmaceuticals Company Profile and Main Business

Table 84. Nanjing Shunxin Pharmaceuticals Recent Developments

Table 85. CSPC OUYI Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 86. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Models, Specifications, and Application

Table 87. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 88. CSPC OUYI Pharmaceutical Company Profile and Main Business

Table 89. CSPC OUYI Pharmaceutical Recent Developments

Table 90. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 91. Qilu Pharmaceutical Targeted Antitumor Drugs Models, Specifications, and Application

Table 92. Qilu Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 93. Qilu Pharmaceutical Company Profile and Main Business

Table 94. Qilu Pharmaceutical Recent Developments

Table 95. Shenzhen Salubris Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 96. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Models, Specifications, and Application

Table 97. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 98. Shenzhen Salubris Pharmaceuticals Company Profile and Main Business

Table 99. Shenzhen Salubris Pharmaceuticals Recent Developments

Table 100. Yaopharma Company Information, Head Office, Market Area, and Industry Position

Table 101. Yaopharma Targeted Antitumor Drugs Models, Specifications, and Application

Table 102. Yaopharma Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 103. Yaopharma Company Profile and Main Business

Table 104. Yaopharma Recent Developments

Table 105. Lianyungang Runzhong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 106. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Models, Specifications, and Application

Table 107. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2020-2025

Table 108. Lianyungang Runzhong Pharmaceutical Company Profile and Main Business

Table 109. Lianyungang Runzhong Pharmaceutical Recent Developments

List of Figures

Figure 1. Targeted Antitumor Drugs Picture

Figure 2. Global Targeted Antitumor Drugs Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Targeted Antitumor Drugs Sales Quantity, (K Units) & (2020-2031)

Figure 4. Global Targeted Antitumor Drugs Average Selling Price (ASP), (2020-2031) & (US$/Unit)

Figure 5. China Targeted Antitumor Drugs Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Targeted Antitumor Drugs Sales Quantity (K Units) & (2020-2031)

Figure 7. China Targeted Antitumor Drugs Average Selling Price (ASP), (US$/Unit) & (2020-2031)

Figure 8. By Consumption Value, China Targeted Antitumor Drugs Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Targeted Antitumor Drugs Market Share of Global, 2020-2031

Figure 10. Global Targeted Antitumor Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Targeted Antitumor Drugs Key Participants, Market Share, 2024

Figure 12. Global Targeted Antitumor Drugs Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Targeted Antitumor Drugs Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Targeted Antitumor Drugs Production Market Share & Forecast by Region, 2020-2031

Figure 15. Targeted Antitumor Drugs Industry Chain

Figure 16. Targeted Antitumor Drugs Procurement Model

Figure 17. Targeted Antitumor Drugs Sales Model

Figure 18. Targeted Antitumor Drugs Sales Channels, Direct Sales, and Distribution

Figure 19. Injection

Figure 20. Tablet

Figure 21. Others

Figure 22. by Type, Global Targeted Antitumor Drugs Consumption Value, 2020-2031, US$ Million

Figure 23. by Type, Global Targeted Antitumor Drugs Consumption Value Market Share, 2020-2031

Figure 24. by Type, Global Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 25. by Type, Global Targeted Antitumor Drugs Sales Quantity Market Share, 2020-2031

Figure 26. by Type, Global Targeted Antitumor Drugs Average Selling Price (ASP), 2020-2031, (US$/Unit)

Figure 27. Lung Cancer

Figure 28. Lymphoma

Figure 29. Breast Cancer

Figure 30. Leukaemia

Figure 31. Prostate Cancer

Figure 32. Multiple Bone Marrow Cancer

Figure 33. Others

Figure 34. by Application, Global Targeted Antitumor Drugs Consumption Value, 2020-2031, US$ Million

Figure 35. by Application, Global Targeted Antitumor Drugs Revenue Market Share, 2020-2031

Figure 36. by Application, Global Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 37. by Application, Global Targeted Antitumor Drugs Sales Quantity Market Share, 2020-2031

Figure 38. by Application, Global Targeted Antitumor Drugs Price, 2020-2031, (US$/Unit)

Figure 39. By Region, Global Targeted Antitumor Drugs Consumption Value Market Share, 2020-2031

Figure 40. By Region, Global Targeted Antitumor Drugs Sales Quantity Market Share, 2020-2031

Figure 41. North America Targeted Antitumor Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country, North America Targeted Antitumor Drugs Consumption Value Market Share, 2024

Figure 43. Europe Targeted Antitumor Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, Europe Targeted Antitumor Drugs Consumption Value Market Share, 2024

Figure 45. Asia Pacific Targeted Antitumor Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. By Country/Region, Asia Pacific Targeted Antitumor Drugs Consumption Value Market Share, 2024

Figure 47. South America Targeted Antitumor Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 48. By Country, South America Targeted Antitumor Drugs Consumption Value Market Share, 2024

Figure 49. Middle East & Africa Targeted Antitumor Drugs Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 50. United States Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 51. by Type, United States Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 52. by Application, United States Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 53. Europe Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 54. by Type, Europe Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 55. by Application, Europe Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 56. China Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 57. by Type, China Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 58. by Application, China Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 59. Japan Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 60. by Type, Japan Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 61. by Application, Japan Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 62. South Korea Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 63. by Type, South Korea Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 64. by Application, South Korea Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 65. Southeast Asia Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 66. by Type, Southeast Asia Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 67. by Application, Southeast Asia Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 68. India Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 69. by Type, India Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 70. by Application, India Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 71. Middle East & Africa Targeted Antitumor Drugs Sales Quantity, 2020-2031, (K Units)

Figure 72. by Type, Middle East & Africa Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 73. by Application, Middle East & Africa Targeted Antitumor Drugs Sales Quantity Market Share, 2024 VS 2031

Figure 74. Research Methodology

Figure 75. Breakdown of Primary Interviews

Figure 76. Bottom-up Approaches

Figure 77. Top-down Approaches